OTC : FAMDF
$0 (0.0%)
OTC
Alex Duggan
Biotechnology
Healthcare
FAMDF
14
GB
USD
0.00
2.06
2.06
1.57
0.00
$1.7M
0.62
0.64
-0.19
-0.01
-$0.0278
-$9.07M
-534.62%
-549.65%
-310.00%
-173.80%
-0.12
0.00
0.00
2/5
0 Analysts
%
-20.11
4/9
$2.3M
$5.22M
$2.41M
-$8.12M
-$2.2M
-1.29
0.40
2.06
-310.00%
-180.43%
-442.18%
-462.95%
-1096 days
| Name | Title |
|---|---|
| Graham Smith | Head of Alliance Partnerships & Supply |
| Alexander James Hanbury Duggan | Chief Executive Officer & Executive Director |
| Angela Hildreth | Chief Operating Officer, Finance Director, Company Secretary & Executive Director |
| William Duncan Potter | Chief Scientific Officer & Adviser to the Board |
| Kenneth William James | Head of R&D & Executive Director |
| Kevin Langridge | Head of Quality |
No votes yet today — be the first to share your view!
About Futura Medical plc (OTC:FAMDF) Stock
Futura Medical plc is a pharmaceutical company that formulates and brings to market healthcare solutions and medicines for the consumer sector, primarily concentrating on sexual well-being and managing discomfort. Their flagship product, MED3000, is a topical gel specifically developed to address erectile dysfunction. The company's pipeline also encompasses a range of pain relief treatments, featuring TPR100, a topical diclofenac gel; CBD100, a topical cannabidiol preparation; and TIB200, a topical ibuprofen gel. Established in 2001, Futura Medical plc operates from its headquarters located in Guildford, United Kingdom. ...
Futura Medical: US Eroxon deal and WSD4000 breakthrough - ICYMI
2026-07-11 06:38:00
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) chief executive Alex Duggan talked with Proactive about the company's new US commercial partnership for...
Futura Medical: US Eroxon deal and WSD4000 breakthrough - ICYMI
2026-07-11 05:46:54
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) chief executive Alex Duggan talked with Proactive about the company's new US commercial partnership for Eroxon and encouraging new clinical data for its women's sexual health product candidate, WSD4000. Duggan explained why Futura Medical selected Market Performance Group (MPG) as its new US commercial partner, highlighting the group's extensive experience in consumer healthcare and its role in managing commercial execution, advertising, distribution and customer operations.
Exxon Mobil updates Q2 earnings considerations, cites impacts across key businesses
2026-07-08 11:30:00
Exxon Mobil Corp (NYSE:XOM, XETRA:XONA) updated its second quarter 2026 earnings considerations after the market close on Tuesday, prompting UBS to slightly...
Futura to appeal European patent decision
2026-07-08 02:44:54
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the pharmaceutical group, said it intends to appeal a European Patent Office decision to revoke its patent for MED3000, the erectile dysfunction treatment sold as Eroxon. It will take the case to the EPO Technical Board of Appeal, a process expected to take at least 18 to 24 months.
Samsung plunges despite earnings beat, sparking fresh AI stock jitters for Nasdaq names
2026-07-07 03:09:00
Samsung Electronics' posted a record quarterly profit on Tuesday but this failed to reassure investors, with the sharp sell-off in the world's largest...
FTSE 100 Live: Stocks slide despite airlines and defence gains, Microsoft slashes jobs
2026-07-06 11:34:00
FTSE 100 down 56 points at 10,623 Pub shares rise after England World Cup win Deal news for easyJet, ITV and defence sector UK construction downturn...
FTSE 100 Live: Stocks slide despite airlines and defence gains, US tech futures rise
2026-07-06 08:13:00
FTSE 100 down 26 points at 10,653 Pub shares rise after England World Cup win Deal news for easyJet, ITV and defence sector UK construction downturn...
FTSE 100 Live: London index at 10-week high as Sainsbury's, miners and banks climb
2026-06-30 08:06:00
FTSE 100 up 123 points at 10,607 Miners climb on higher copper prices Sainsbury's Q1 update impresses 12.05pm: FTSE at 10-week high The FTSE 100 has...
Frequently Asked Questions
What is the current Futura Medical plc (FAMDF) stock price?
Futura Medical plc(OTC:FAMDF) stock price is $0.0107 in the last trading session. During the trading session, FAMDF stock reached the peak price of $0.2 while $0.0013 was the lowest point it dropped to. The percentage change in FAMDF stock occurred in the recent session was 0.0% while the dollar amount for the price change in FAMDF stock was $0.
FAMDF's industry and sector of operation?
The OTC listed FAMDF is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of FAMDF?
Graham Smith
| Head of Alliance Partnerships & Supply
Alexander James Hanbury Duggan
| Chief Executive Officer & Executive Director
Angela Hildreth
| Chief Operating Officer, Finance Director, Company Secretary & Executive Director
William Duncan Potter
| Chief Scientific Officer & Adviser to the Board
Kenneth William James
| Head of R&D & Executive Director
How many employees does FAMDF have?
Number of FAMDF employees currently stands at 14. FAMDF operates from Surrey Technology Centre, Guildford, SU GU2 7YG, GB.
Link for FAMDF official website?
Official Website of FAMDF is: https://www.futuramedical.com
How do I contact FAMDF?
FAMDF could be contacted at phone #44 14 8368 5670 and can also be accessed through its website. FAMDF operates from Surrey Technology Centre, Guildford, SU GU2 7YG, GB.
How many shares of FAMDF are traded daily?
The average number of FAMDF shares traded daily for last 3 months was 16.67K.
What is the market cap of FAMDF currently?
The market value of FAMDF currently stands at $3.63M with its latest stock price at $0.0107